Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patients.
Saved in:
| Title: | Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patients. |
|---|---|
| Authors: | Lin MH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan., Ye RH; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan., Jhou HJ; Neurological Institute, Changhua Christian Hospital, Changhua, Taiwan., Chen HY; Department of Family Medicine, Chi Mei Medical Center, Tainan, Taiwan., Kao LT; Graduate Institute of Life Sciences, National Defense Medical University, Taipei, Taiwan.; School of Pharmacy, National Defense Medical University, Taipei, Taiwan.; Department of Pharmacy Practice, Tri-Service General Hospital, Taipei, Taiwan., Hsieh TY; Department of Obstetrics & Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Chen YH; Department of Internal Medicine, Englewood Hospital and Medical Center, Englewood, NJ, USA., Yue-En Sun A; College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., Zhang X; Department of Internal Medicine, NYC Health + Hospitals/Jacobi, Albert Einstein College of Medicine, Bronx, NY, USA., Dai MS; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan., Ho CL; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.; Division of Hematology and Oncology, Medical Department, Taipei Tzu Chi Hospital, Taipei, Taiwan., Chen PH; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan. chenpohuang@hotmail.com., Lee CH; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan. drleechohao@gmail.com. |
| Source: | Diabetology & metabolic syndrome [Diabetol Metab Syndr] 2025 Oct 03; Vol. 17 (1), pp. 377. Date of Electronic Publication: 2025 Oct 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101488958 Publication Model: Electronic Cited Medium: Print ISSN: 1758-5996 (Print) Linking ISSN: 17585996 NLM ISO Abbreviation: Diabetol Metab Syndr Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41044787 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lin+MH%22">Lin MH</searchLink>; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Ye+RH%22">Ye RH</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Jhou+HJ%22">Jhou HJ</searchLink>; Neurological Institute, Changhua Christian Hospital, Changhua, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+HY%22">Chen HY</searchLink>; Department of Family Medicine, Chi Mei Medical Center, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Kao+LT%22">Kao LT</searchLink>; Graduate Institute of Life Sciences, National Defense Medical University, Taipei, Taiwan.; School of Pharmacy, National Defense Medical University, Taipei, Taiwan.; Department of Pharmacy Practice, Tri-Service General Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hsieh+TY%22">Hsieh TY</searchLink>; Department of Obstetrics & Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+YH%22">Chen YH</searchLink>; Department of Internal Medicine, Englewood Hospital and Medical Center, Englewood, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Yue-En+Sun+A%22">Yue-En Sun A</searchLink>; College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Department of Internal Medicine, NYC Health + Hospitals/Jacobi, Albert Einstein College of Medicine, Bronx, NY, USA.<br /><searchLink fieldCode="AU" term="%22Dai+MS%22">Dai MS</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Ho+CL%22">Ho CL</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.; Division of Hematology and Oncology, Medical Department, Taipei Tzu Chi Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+PH%22">Chen PH</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan. chenpohuang@hotmail.com.<br /><searchLink fieldCode="AU" term="%22Lee+CH%22">Lee CH</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan. drleechohao@gmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101488958%22">Diabetology & metabolic syndrome</searchLink> [Diabetol Metab Syndr] 2025 Oct 03; Vol. 17 (1), pp. 377. <i>Date of Electronic Publication: </i>2025 Oct 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101488958 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1758-5996 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217585996%22">17585996 </searchLink><i>NLM ISO Abbreviation: </i>Diabetol Metab Syndr <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41044787 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13098-025-01940-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 377 Titles: – TitleFull: Immune checkpoint inhibitor therapy and risk of type 1 diabetes mellitus in metastatic cancer patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lin MH – PersonEntity: Name: NameFull: Ye RH – PersonEntity: Name: NameFull: Jhou HJ – PersonEntity: Name: NameFull: Chen HY – PersonEntity: Name: NameFull: Kao LT – PersonEntity: Name: NameFull: Hsieh TY – PersonEntity: Name: NameFull: Chen YH – PersonEntity: Name: NameFull: Yue-En Sun A – PersonEntity: Name: NameFull: Zhang X – PersonEntity: Name: NameFull: Dai MS – PersonEntity: Name: NameFull: Ho CL – PersonEntity: Name: NameFull: Chen PH – PersonEntity: Name: NameFull: Lee CH IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 10 Text: 2025 Oct 03 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 1758-5996 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Diabetology & metabolic syndrome Type: main |
| ResultId | 1 |